Alternative Therapies in Health and Medicine, 2023/05, 29(4):76-81, type of study: ,rct,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

Full text    (http://www.alternative-therapies.com/abstract/index.html?id=36045)

Keywords:

low back pain [524]
osteopathic manipulative treatment [3946]
OMT [3925]
chronic pain [324]
Kaltenborn-Evjenth orthopedic manual therapy [1]
randomized controlled trial [947]

Abstract:

CONTEXT: Low back pain (LBP) is a painful pathology causing pain and disability despite treatment with the best evidence-based therapies. Osteopathic manual therapy (OMT) and Kaltenborn-Evjenth orthopedic manual therapy (KEOMT) are alternative treatments for LBP. OBJECTIVE: The study intended to evaluate the efficacy of OMT compared to that of KEOMT for patients with chronic LBP. DESIGN: The research team designed a randomized study. SETTING: The study was held at the Medita Health Center in Warsaw, Poland. PARTICIPANTS: The study included 68 participants of both genders, aged 30 to 60, with chronic LBP. INTERVENTION: Participants were randomly assigned to one of two parallel groups, each with 34 members. The OMT group received, as a direct technique, a high-velocity/low-amplitude (HVLA) impulse, and as indirect techniques, strain counterstrain (SCS), myofascial release (MFR), and visceral mobilization therapy (VMT). The KEOMT group received lumbar segmental traction and lumbar segmental mobilization-flexion and gliding therapy grade 3. The participants in both groups received 10 treatments, two per week for five weeks. OUTCOME MEASURES: The primary outcome was pain severity, using a numeric pain rating scale (NPRS). The secondary outcome was measurement of functional disability, using the Oswestry Disability Index (ODI). RESULTS: The OMT and KEOMT both decreased pain and disability; however, the changes on the NPRS and ODI postintervention were statistically greater for the OMT group compared to the KEOMT group (P < .05). CONCLUSIONS: OMT was better at reducing pain and improving quality of life. It reduced functional disability more than KEOMT in patients with chronic LBP.